China Universal Asset Management Co., Ltd. Biomarin Pharmaceutical Inc Transaction History

China Universal Asset Management Co., Ltd.

$773 Million
Q1 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 36,621 shares of BMRN stock, worth $2.97 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

36,621

Previous 36,621 -0.0%

Holding current value

$2.97 Million

Previous $3.2 Million -0.0%

% of portfolio

0.41%

Previous 0.41%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$83.81 - $99.0 $1.21 Million - $1.43 Million	14,465 Added 65.29%	36,621 $3.2 Million
Q4 2023 May 21, 2024	SELL	$76.22 - $98.51 $1.1 Million - $1.42 Million	-14,465 Reduced 39.5%	22,156 $2.14 Million
Q4 2023 Jan 23, 2024	BUY	$76.22 - $98.51 $1.01 Million - $1.31 Million	13,270 Added 149.34%	22,156 $2.14 Million
Q3 2023 May 21, 2024	BUY	$85.07 - $94.48 $201,786 - $224,106	2,372 Added 36.41%	8,886 $786,000
Q3 2023 Oct 30, 2023	BUY	$85.07 - $94.48 $201,786 - $224,106	2,372 Added 36.41%	8,886 $786,000

Q2 2023 May 21, 2024	SELL	$86.68 - $100.3 $5,720 - $6,619	-66 Reduced 1.0%	6,514 $564,000
Q2 2023 Jul 27, 2023	SELL	$86.68 - $100.3 $5,720 - $6,619	-66 Reduced 1.0%	6,514 $565,000
Q1 2023 May 21, 2024	SELL	$87.74 - $117.27 $1.7 Million - $2.27 Million	-19,350 Reduced 74.62%	6,580 $639,000
Q1 2023 Apr 27, 2023	SELL	$87.74 - $117.27 $1.7 Million - $2.27 Million	-19,350 Reduced 74.62%	6,580 $640,000
Q4 2022 May 21, 2024	SELL	$80.93 - $108.63 $865,222 - $1.16 Million	-10,691 Reduced 29.19%	25,930 $2.68 Million
Q4 2022 Jan 31, 2023	SELL	$80.93 - $108.63 $318,702 - $427,784	-3,938 Reduced 13.18%	25,930 $2.68 Million
Q3 2022 Oct 21, 2022	BUY	$82.16 - $96.94 $142,711 - $168,384	1,737 Added 6.17%	29,868 $2.53 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $1.52 Million - $1.85 Million	21,271 Added 310.07%	28,131 $2.33 Million
Q1 2022 Apr 25, 2022	BUY	$74.28 - $92.69 $509,560 - $635,853	6,860 New	6,860 $529,000

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Biomarin Pharmaceutical Inc Transaction History